Improving healthcare through technology innovation

Delivering technology advisory services and innovation management to industry and the NHS

MedTech Consulting

Essential insights, knowledge and evidence to successfully develop and commercialise health technologies.

Technology Commercialisation

Expert advice and practical hands-on support for NHS and other organisations bringing innovative technologies to market.

Funding

Identify, evaluate and pitch for funding & investment for the different stages of product development and commercialisation.

Training and Entrepreneurship

Entrepreneurship skills training for individuals and teams. specific to the medical technology sector.

PROVEN HEALTHCARE INNOVATION

At Health Enterprise East we believe in improving healthcare through technology and innovation. We are uniquely connected with the NHS, medical technology industry and governmental organisations, and provide practical advice and hands on support to innovators at different stages of the product development pathway. We have a successful track record in developing and commercialising new medical innovations for the benefit of patients.

Meet the team

Latest News

View all the latest news stories and events from Health Enterprise East plus a selection of other articles and events from partner agencies/organisations which may be of interest.

News

Medovate’s game-changing anaesthesia device SAFIRA® receives European CE regulatory approval

16th September, 2020

Medovate – a pioneering medical device development company specialising in anaesthesia, airway management, critical care, and surgery – announced it has received CE Mark Approval for its game-changing medical device SAFIRA® (SAFer Injection for Regional Anaesthesia).

News

Medovate announces distribution agreement with LTR Medical for sales of SAFIRA® in Australia and New Zealand

9th September, 2020

Medovate, HEE’s medical device development partner, has concluded a distribution agreement with Brisbane-based, LTR Medical which will provide exclusivity for SAFIRA® (SAFer Injection for Regional Anaesthesia) in Australia and New Zealand.

News

Ablatus awarded over £1m Innovate UK grant for next-generation tumour ablation treatment

26th August, 2020

Cambridge-based Ablatus Therapeutics Limited has been awarded £1.4m by the UK government’s Innovate UK to develop its next-generation, minimally-invasive treatment for soft tissue tumours. The award will fund a 2-year project to develop the prototype device into a final version for use in patients for the first time.

GUIDANCE AT EVERY STAGE

HEE works with the NHS and medtech companies to help  turn innovative ideas into products and services that will benefit patients, the NHS and the wider economy.

Case Studies

Keep up to date with all HEE news and events.

We take your data very seriously, please read our privacy policy.